Design Therapeutics, Inc.

Contributing Author

Recent Articles by Design Therapeutics, Inc.

May-13	Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference DSGN GlobeNewswire
May-07	Design Therapeutics Highlights Momentum Across Lead GeneTAC Programs and Reports First Quarter 2025 Financial Results DSGN GlobeNewswire
May-01	Design Therapeutics Announces Favorable Phase 1 Data for DT-168 Supporting Advancement into Phase 2 Biomarker Trial for Patients with Fuchs Endothelial Corneal Dystrophy DSGN GlobeNewswire